Gelber, Richard D.
Dana-Farber Cancer Institute,
United States
2025 Rank: 102205
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 3105 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102205 | 113834 |
| Total Cites | 3375 | 3540 |
| H-index | 28 | 29 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 12 | 12 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 280 | 286 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2565 | 2636 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.34 |
| Self-Citation Percentage |
4.66%
|
|
Gelber, Richard D.
Harvard Medical School,
United States
2024 Rank: 65359
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2123 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65359 | 68689 |
| Total Cites | 4141 | 4394 |
| H-index | 29 | 30 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 22 | 22 |
| Number of Single+First+Last Authored Papers | 122 | 122 |
| Total Cites to Single+First+Last Authored Papers | 319 | 338 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2989 | 3081 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.43 |
| Self-Citation Percentage |
5.76%
|
|
Gelber, Richard D.
Dana-Farber Cancer Institute,
United States
2022 Rank: 67980
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2598 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67980 | 77698 |
| Total Cites | 4736 | 5045 |
| H-index | 32 | 33 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 10 | 10 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 330 | 344 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 3331 | 3433 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.47 |
| Self-Citation Percentage |
6.12%
|
|
Gelber, Richard D.
Harvard Medical School,
United States
2020 Rank: 43341
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1515 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43341 | 46540 |
| Total Cites | 5893 | 6421 |
| H-index | 38 | 39 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 25 | 25 |
| Number of Single+First+Last Authored Papers | 124 | 124 |
| Total Cites to Single+First+Last Authored Papers | 540 | 568 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3958 | 4129 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.56 |
| Self-Citation Percentage |
8.22%
|
|
Related Profiles
Featured Profiles
Partner with Us
📢 Reach a targeted audience of science enthusiasts and professionals through our platform. Contact our marketing team:
business@topscinet.com cc: top2percentscientist@gmail.comGet a custom proposal tailored to your banner ad goals.
Partner with Us
📢 Partner with us and reach a targeted audience of science enthusiasts and professionals through our platform. Your company/institute’s banner could be here.